Additionally, a tendency toward lower CD31 (p = 0.09) and CCR3 expression (p = 0.10), and higher CD69 (p = 0.07) and CD29 expression (p = 0.15) was observed on neutrophils from late-stage melanoma patients compared to healthy donors, which were all not statistically significant. This evidence concerns the gene CCR3 and melanoma.